January 23, 2025 - 13:33

Seagate Technology Holdings has released its financial results for the second quarter of 2025, revealing a mixed performance that has raised concerns among investors. The company reported revenue of $2.33 billion, marking a significant increase of 50% compared to the previous year. However, the earnings per share (EPS) fell short of analysts' expectations, leading to a decline in the company's stock price.
The increase in revenue can be attributed to strong demand for data storage solutions, particularly in the cloud and enterprise sectors. Despite the positive revenue growth, the EPS miss has sparked discussions about the company's cost management strategies and overall profitability. Analysts had anticipated a more robust performance, and the shortfall could prompt a reevaluation of future earnings projections.
As the technology landscape continues to evolve, Seagate faces challenges in maintaining its competitive edge. Investors will be closely monitoring the company's strategic initiatives and market positioning in the coming quarters to better understand its path forward.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...